Cabozantinib Cabozantinib is an oral tyrosine kinase inhibitor of RET receptor kinase, hepatocyte growth factor receptor MET, and VEGFR-2
Glutathione and Vitamin C synergistically replenish and recycle each other, delivering enhanced benefits when administered through IV therapy or oral supplements
How Semaglutide and Tirzepatide Work When you eat, your digestive tract releases the hormone glucagon-like peptide-1 (GLP-1), which spurs your body to create more insulin
Currently, semaglutide is prescribed at a 2.4mg dose for treating obesity
Over the past few years, multiple case reports have described the associations between GLP-1 agonist use and improvement of dermatologic conditions, particularly those associated with T2DM and obesity, including HS and psoriasis